| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of General Surgery, Nutrition and Toxicology Research Institute Maastricht, and
Department of Clinical and Experimental Immunology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands; and
Institute of Medical Microbiology, Medical School Hannover, Hannover, Germany
The complement system has been shown to mediate renal ischemia-reperfusion (I/R) injury. However, the contribution of complement factor C5a to I/R injury, in particular in the kidney, remains to be established. In this study, we investigated the impact of blocking the C5aR pathway on the inflammatory response and on the renal function in a murine model of I/R injury. First, we analyzed C5aR expression in kidneys of healthy mice. Intriguingly, we found expression on mesangial, as well as on tubular epithelial, cells. After I/R injury, C5aR expression was up-regulated in tubular epithelial cells. In addition, mRNA levels of CXC chemokines and TNF-
increased significantly and kidneys were heavily infiltrated by neutrophils. Blocking the C5aR pathway by a specific C5a receptor antagonist (C5aRA) abrogated up-regulation of CXC chemokines but not of TNF- and reduced neutrophil infiltration by >50%. Moreover, application of the C5aRA significantly reduced loss of renal function. This improvement of function was independent of the presence of neutrophils because neutrophil depletion by mAb NIMP-R14 did not affect the protective effect of C5aRA treatment. Furthermore, blocking of the C5aR pathway had no influence on renal apoptosis. These data provide evidence that C5a is crucially involved in the pathogenesis of renal I/R injury by modulation of neutrophil-dependent as well as neutrophil-independent pathways, which include the regulation of CXC chemokines but not TNF- or apoptotic pathways.
This article has been cited by other articles:
|
|
 |
|
  S. Kumar, D. A. Allen, J. E. Kieswich, N. S. A. Patel, S. Harwood, E. Mazzon, S. Cuzzocrea, M. J. Raftery, C. Thiemermann, and M. M. Yaqoob Dexamethasone Ameliorates Renal Ischemia-Reperfusion Injury J. Am. Soc. Nephrol., November 1, 2009; 20(11): 2412 - 2425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. La Bonte, B. Dokken, G. Davis-Gorman, G. L. Stahl, and P. F. McDonagh The mannose-binding lectin pathway is a significant contributor to reperfusion injury in the type 2 diabetic heart Diabetes and Vascular Disease Research, July 1, 2009; 6(3): 172 - 180. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Pan, Z. Shen, P. Mukhopadhyay, H. Wang, P. Pacher, X. Qin, and B. Gao Anaphylatoxin C5a contributes to the pathogenesis of cisplatin-induced nephrotoxicity Am J Physiol Renal Physiol, March 1, 2009; 296(3): F496 - F504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-X. Zhang, S. Wang, X. Huang, W.-P. Min, H. Sun, W. Liu, B. Garcia, and A. M. Jevnikar NK Cells Induce Apoptosis in Tubular Epithelial Cells and Contribute to Renal Ischemia-Reperfusion Injury J. Immunol., December 1, 2008; 181(11): 7489 - 7498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Gueler, S. Rong, W. Gwinner, M. Mengel, V. Brocker, S. Schon, T. F. Greten, H. Hawlisch, T. Polakowski, K. Schnatbaum, et al. Complement 5a Receptor Inhibition Improves Renal Allograft Survival J. Am. Soc. Nephrol., December 1, 2008; 19(12): 2302 - 2312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wu, M. L. Craft, P. Wang, K. R. Wyburn, G. Chen, J. Ma, B. Hambly, and S. J. Chadban IL-18 Contributes to Renal Damage after Ischemia-Reperfusion J. Am. Soc. Nephrol., December 1, 2008; 19(12): 2331 - 2341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. S. Sheerin Should Complement Activation Be a Target for Therapy in Renal Transplantation? J. Am. Soc. Nephrol., December 1, 2008; 19(12): 2250 - 2251. [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zheng, X. Zhang, B. Feng, H. Sun, M. Suzuki, T. Ichim, N. Kubo, A. Wong, L. R. Min, M. E. Budohn, et al. Gene Silencing of Complement C5a Receptor Using siRNA for Preventing Ischemia/Reperfusion Injury Am. J. Pathol., October 1, 2008; 173(4): 973 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Gueler, S. Rong, M. Mengel, J.-K. Park, J. Kiyan, T. Kirsch, I. Dumler, H. Haller, and N. Shushakova Renal Urokinase-Type Plasminogen Activator (uPA) Receptor but not uPA Deficiency Strongly Attenuates Ischemia Reperfusion Injury and Acute Kidney Allograft Rejection J. Immunol., July 15, 2008; 181(2): 1179 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. La Bonte, G. Davis-Gorman, G. L. Stahl, and P. F. McDonagh Complement inhibition reduces injury in the type 2 diabetic heart following ischemia and reperfusion Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1282 - H1290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. McFarlane, C. Perez, M. Charmoy, C. Allenbach, K. C. Carter, J. Alexander, and F. Tacchini-Cottier Neutrophils Contribute to Development of a Protective Immune Response during Onset of Infection with Leishmania donovani Infect. Immun., February 1, 2008; 76(2): 532 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Roos, M. R. Daha, J. van Pelt, and S. P. Berger Mannose-binding lectin and the kidney Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3370 - 3377. [Full Text] [PDF]
|
|
|
|
|
|
M. Kim, M. Kim, N. Kim, V. D. D'Agati, C. W. Emala Sr, and H. T. Lee Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1827 - F1835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Matthijsen, D. Huugen, N. T. Hoebers, B. de Vries, C. J. Peutz-Kootstra, Y. Aratani, M. R. Daha, J. W. C. Tervaert, W. A. Buurman, and P. Heeringa Myeloperoxidase Is Critically Involved in the Induction of Organ Damage after Renal Ischemia Reperfusion Am. J. Pathol., December 1, 2007; 171(6): 1743 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Thurman, A. M. Lenderink, P. A. Royer, K. E. Coleman, J. Zhou, J. D. Lambris, R. A. Nemenoff, R. J. Quigg, and V. M. Holers C3a Is Required for the Production of CXC Chemokines by Tubular Epithelial Cells after Renal Ishemia/Reperfusion J. Immunol., February 1, 2007; 178(3): 1819 - 1828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Duffield, S. Hong, V. S. Vaidya, Y. Lu, G. Fredman, C. N. Serhan, and J. V. Bonventre Resolvin D Series and Protectin D1 Mitigate Acute Kidney Injury J. Immunol., November 1, 2006; 177(9): 5902 - 5911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Ascon, S. Lopez-Briones, M. Liu, M. Ascon, V. Savransky, R. B. Colvin, M. J. Soloski, and H. Rabb Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. J. Immunol., September 1, 2006; 177(5): 3380 - 3387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Devarajan Update on Mechanisms of Ischemic Acute Kidney Injury J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1503 - 1520. [Full Text] [PDF]
|
|
|
|
|
|
H. Patel, R. A.G. Smith, S. H. Sacks, and W. Zhou Therapeutic Strategy with a Membrane-Localizing Complement Regulator to Increase the Number of Usable Donor Organs after Prolonged Cold Storage J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1102 - 1111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Thurman, P. A. Royer, D. Ljubanovic, B. Dursun, A. M. Lenderink, C. L. Edelstein, and V. M. Holers Treatment with an Inhibitory Monoclonal Antibody to Mouse Factor B Protects Mice from Induction of Apoptosis and Renal Ischemia/Reperfusion Injury J. Am. Soc. Nephrol., March 1, 2006; 17(3): 707 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Farrar, W. Zhou, T. Lin, and S. H. Sacks Local extravascular pool of C3 is a determinant of postischemic acute renal failure FASEB J, February 1, 2006; 20(2): 217 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bao, I. Osawe, M. Haas, and R. J. Quigg Signaling through Up-Regulated C3a Receptor Is Key to the Development of Experimental Lupus Nephritis J. Immunol., August 1, 2005; 175(3): 1947 - 1955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Xiao, P. Heeringa, Z. Liu, D. Huugen, P. Hu, N. Maeda, R. J. Falk, and J. C. Jennette The Role of Neutrophils in the Induction of Glomerulonephritis by Anti-Myeloperoxidase Antibodies Am. J. Pathol., July 1, 2005; 167(1): 39 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Shushakova, N. Tkachuk, M. Dangers, S. Tkachuk, J.-K. Park, K. Hashimoto, H. Haller, and I. Dumler Urokinase-induced activation of the gp130/Tyk2/Stat3 pathway mediates a pro-inflammatory effect in human mesangial cells via expression of the anaphylatoxin C5a receptor J. Cell Sci., June 15, 2005; 118(12): 2743 - 2753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Abonia, D. S. Friend, W. G. Austen Jr., F. D. Moore Jr., M. C. Carroll, R. Chan, J. Afnan, A. Humbles, C. Gerard, P. Knight, et al. Mast Cell Protease 5 Mediates Ischemia-Reperfusion Injury of Mouse Skeletal Muscle J. Immunol., June 1, 2005; 174(11): 7285 - 7291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. de Vries, S. J. Walter, C. J. Peutz-Kootstra, T. G.A.M. Wolfs, L.W. E. van Heurn, and W. A. Buurman The Mannose-Binding Lectin-Pathway Is Involved in Complement Activation in the Course of Renal Ischemia-Reperfusion Injury Am. J. Pathol., November 1, 2004; 165(5): 1677 - 1688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Turnberg, M. Botto, M. Lewis, W. Zhou, S. H. Sacks, B. P. Morgan, M. J. Walport, and H. T. Cook CD59a Deficiency Exacerbates Ischemia-Reperfusion Injury in Mice Am. J. Pathol., September 1, 2004; 165(3): 825 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. J. Kim, I. D. Dimitriou, M. C. H. Holland, D. Mastellos, Y. M. Mueller, J. D. Altman, J. D. Lambris, and P. D. Katsikis Complement C5a Receptor Is Essential for the Optimal Generation of Antiviral CD8+ T Cell Responses J. Immunol., August 15, 2004; 173(4): 2524 - 2529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yamada, T. Miwa, J. Liu, M. Nangaku, and W.-C. Song Critical Protection from Renal Ischemia Reperfusion Injury by CD55 and CD59 J. Immunol., March 15, 2004; 172(6): 3869 - 3875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Otto, H. Hawlisch, P. N. Monk, M. Muller, A. Klos, C. L. Karp, and J. Kohl C5a Mutants Are Potent Antagonists of the C5a Receptor (CD88) and of C5L2: POSITION 69 IS THE LOCUS THAT DETERMINES AGONISM OR ANTAGONISM J. Biol. Chem., January 2, 2004; 279(1): 142 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Quigg Complement and the Kidney J. Immunol., October 1, 2003; 171(7): 3319 - 3324. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Burne-Taney, D. B. Ascon, F. Daniels, L. Racusen, W. Baldwin, and H. Rabb B Cell Deficiency Confers Protection from Renal Ischemia Reperfusion Injury J. Immunol., September 15, 2003; 171(6): 3210 - 3215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. de Vries, R. A. Matthijsen, A. A. J. H. M. van Bijnen, T. G. A. M. Wolfs, and W. A. Buurman Lysophosphatidic Acid Prevents Renal Ischemia-Reperfusion Injury by Inhibition of Apoptosis and Complement Activation Am. J. Pathol., July 1, 2003; 163(1): 47 - 56. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
